Sensus Healthcare, Inc.
NASDAQ:SRTSMedical - Devices
+$0.09 today
- Market cap
- $53.01M
- Beta
- 1.09
- P/E (TTM)
- -6.5
- EPS (TTM)
- -$0.47
Volume 0.08M
Average 0.06M
SRTS Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
Sensus Healthcare, Inc.NASDAQ: SRTS
Net Receivables · Q1 FY2026 · quarter ended Mar 2026
Net receivables falls 80.1% from a year ago
Net receivables stood at $3.58M at the end of Q1 FY2026, down 80.1% from a year earlier and down 40.8% from the prior quarter. Over 3 fiscal years it compounded at -29.6% a year.
Context
- Net receivables amounted to 6.9% of total assets at the end of Q1 FY2026, down 23.0 pp from a year earlier.
- Net receivables increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -80.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 6.04M USD
- Year-over-year change
- -69.4%
- 4-year CAGR
- -16.0%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.04M | -69.4% |
| FY2024 | 2024-12-31 | 19.73M | +85.4% |
| FY2023 | 2023-12-31 | 10.65M | -38.5% |
| FY2022 | 2022-12-31 | 17.3M | +42.6% |
| FY2021 | 2021-12-31 | 12.13M | — |
Net Receivables vs competitors
How SRTS compares with its peers on the latest reported figures
- SRTS's Mar 2026 net receivables of $3.58M is the 4th highest of the 6 companies compared; the peer median is $9.64M.
- Its year-over-year change of -80.1% is the 5th highest of 6, against a peer median of -33.7%.
- Net receivables amounts to 6.9% of total assets for SRTS, versus a peer median of 16.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
BDMDBaird Medical Investment Holdings Limited | Dec 2025 | $42.53M | -8.7% | +19.8% | 61.0% |
| Mar 2026 | $23.36M | -33.7% | -17.8% | 17.8% | |
| Jun 2026 | $9.64M | -23.1% | +16.0% | 16.1% | |
| Mar 2026 | $3.58M | -80.1% | -29.6% | 6.9% | |
MDAISpectral AI, Inc. | Mar 2026 | $1.19M | -43.7% | -24.2% | 6.7% |
| Mar 2026 | $0 | -100.0% | -5.1% | 0.0% | |
| Peer median (excluding SRTS) | $9.64M | -33.7% | -5.1% | 16.1% | |
Competitors are the stored peer set for SRTS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 14.52M | 25.52M | 23.15M | 22.06M | 22.08M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 12.13M | 17.3M | 10.65M | 19.73M | 6.04M |
| Inventory | 1.76M | 3.5M | 11.86M | 10.1M | 14.56M |
| Other Current Assets | 268K | 660K | 888K | 1.51M | 1.68M |
| Total Current Assets | 31.25M | 53.24M | 49.53M | 56.74M | 45.89M |
| Property, Plant & Equipment (Net) | 774K | 1.24M | 1.24M | 2.58M | 2.43M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 146K | 50K | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 1.71M | 2.14M | 2.2M | 4.08M |
| Other Non-current Assets | 75K | 492K | 804K | 652K | 640K |
| Total Non-current Assets | 995K | 3.49M | 4.18M | 5.43M | 7.15M |
| Total Assets | 32.24M | 56.74M | 53.71M | 62.17M | 53.04M |
| Account Payables | 4.06M | 5.52M | 2.79M | 4.81M | 3.34M |
| Short-term Debt | 51K | 0 | 0 | 0 | 262K |
| Tax Payables | 0 | 890K | 37K | 0 | 0 |
| Deferred Revenue | 1.17M | 693K | 657K | 541K | 842K |
| Other Current Liabilities | 508K | 403K | 538K | 329K | 275K |
| Total Current Liabilities | 5.96M | 7.7M | 4.21M | 5.89M | 4.72M |
| Long-term Debt | 0 | 0 | 0 | 0 | 209K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 262K | 139K | 60K | 55K | 10K |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | (209K) |
| Total Non-current Liabilities | 262K | 969K | 656K | 453K | 219K |
| Total Liabilities | 6.23M | 8.67M | 4.87M | 6.34M | 4.94M |
| Common Stock | 167K | 169K | 169K | 169K | 169K |
| Retained Earnings | (17.94M) | 6.3M | 6.79M | 13.43M | 5.72M |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 26.02M | 48.07M | 48.84M | 55.83M | 48.1M |
| Total Debt | 225K | 1.02M | 783K | 602K | 680K |
| Net Debt | (14.29M) | (24.5M) | (22.37M) | (21.45M) | (21.4M) |
Sensus Healthcare, Inc.
NASDAQ:SRTS
Intrinsic Alpha fair value
Locked
Current Price
$3.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.